• DELTA HEALTH has entered into a bilateral, multi-year, mutual exclusivity agreement with the MLP Care Group of Hospitals and Istinye University Turkey, with the primary focus on the advancement of innovative medical care. In addition to other health-care related activities, it also includes exclusively developing and conducting international Phase 3 drug development clinical trials at the MLP Care owned hospitals and clinics. MLP Care is the largest hospital group of Turkey and owns 32 state-of-the-art modern hospitals in the country.....[May 2021]

  • The DELTA HEALTH GROUP Global Products Division commences operation as an international source of innovative healthcare product-lines.....[May 2021] 

  • To combat the challenges of the COVID-19 pandemic, DELTA HEALTH is participating in the US National Institutes of Health (NIH) ACTIV clinical program in collaboration with prominent researchers and physician-scientists from the University of California.....[January 2021] 

  • The DELTA HEALTH specialist physicians are operating humanitarian medical clinics to serve underprivileged COVID-19 patients in Asia.....[January 2021] 

  • DELTA HEALTH has partnered with its strategic affiliate company to collaborate on the US Government Operation Warp Speed (OWS) project focused on clinical trials exploring potential treatment options for COVID-19.....[January 2021] 

  • DELTA HEALTH has entered into a collaborative agreement with a multinational consortium to provide clinical development expertise for global interventional clinical trials related to the treatment of hospitalized COVID-19 patients.....[October 2020] 

  • DELTA HEALTH is supporting an international clinical development program and its in-life phase clinical trial for a drug used for the treatment of insulin-induced hypoglycemia in Diabetics.....[September 2020] 

  • DELTA HEALTH has entered into an agreement with its strategic partner company to provide clinical development expertise for global interventional clinical trials related to an oral treatment of COVID-19.....[August 2020] 

  • DELTA HEALTH is supporting international drug development clinical trials in the indication for Myelofibrosis.....[June 2020] 

  • The DELTA HEALTH team has risen up to the global challenge by strategically partnering with a start-up biotech company spearheading the development of a vaccine against COVID-19.....[May 2020]